A reappraisal of the clinical spectrum of North Carolina macular dystrophy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19616854.
- Also identified by DOI 10.1016/j.ophtha.2009.03.028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To characterize the clinical phenotypes and genotype of a large family with North Carolina macular dystrophy (NCMD). Observational, retrospective case series. Thirteen participants who were at risk of inheriting a dominantly transmitted disease gene from a 4-generation family from Baltimore were examined. Thirteen participants underwent ophthalmic examination and genomic linkage analysis. Fundus photography, spectral-domain optical coherence tomography (SD-OCT), fluorescein angiography, ultrasonography, full-field electroretinography, and electro-oculography were performed on some patients. Description of clinical phenotypes with genomic linkage to the MCDR1 locus. Nine of 13 participants were affected with NCMD. There are variable and previously unreported clinical manifestations among affected individuals with NCMD, including drusen, macular staphyloma, choroidal neovascularization, a retinal pigment epithelial tear, and geographic atrophy. The distinctive and virtually pathognomonic grade 3 lesions in NCMD are neither staphylomas nor colobomas, as previously thought. As shown by ultrasonography and SD-OCT, they are deep chorioretinal excavations not involving the sclera, for which the authors propose a new term: macular caldera. Linkage analysis was performed, and the disease-causing gene in this family was mapped to the MCDR1 locus. North Carolina macular dystrophy has a wide spectrum of clinical phenotypes that resemble age-related macular degeneration except for their early age of onset.
Medical subject headings
- Chromosomes, Human, Pair 6
- Eye Proteins
- Macular Degeneration